| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Sabba Stephen L serves as a Director at LGND and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 0 buys and 11 sells. Those positions are worth an estimated $9.0M at current prices.
The biggest single holding is LGNZZ (~$6.8M) as Director. The recent filings there lean toward selling, a net 3,034 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | LGNYZ Ligand Pharmaceuticals Incorporated | Director | Sale+OE | 2,145 | $254.00 | $544,830.00 | -6.0% | - | - | |
| Mar 23, 2026 | LGNZZ Ligand Pharmaceuticals Incorporated | Director | Sell | 1,000 | $207.87 | $207,872.70 | -3.0% | - | - | |
| Mar 3, 2026 | LGNZZ Ligand Pharmaceuticals Incorporated | Director | Sale+OE | 2,034 | $201.50 | $409,851.00 | -5.7% | - | - | |
| Mar 5, 2024 | LGND Ligand Pharmaceuticals Inc | Director | Sale+OE | 1,893 | $74.30 | $140,649.90 | -6.1% | +18.8% | +56.0% | |
| May 10, 2023 | LGND Ligand Pharmaceuticals Inc | Director | Sale+OE | 6,408 | $77.13 | $494,224.69 | -19.9% | -13.5% | +11.0% | |
| Feb 9, 2021 | LGND Ligand Pharmaceuticals Inc | Director | Sale+OE | 14,670 | $208.53 | $3,059,122.70 | -37.5% | - | - | |
| Jul 31, 2019 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 4,091 | $94.45 | $386,394.95 | -14.8% | - | - | |
| Sep 4, 2018 | LGND Ligand Pharmaceuticals Inc | Director | Sale+OE | 5,000 | $255.05 | $1,275,250.00 | -15.7% | - | - | |
| Mar 12, 2018 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 622 | $180.73 | $112,414.06 | -2.3% | - | - | |
| Dec 20, 2017 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 925 | $137.25 | $126,956.25 | -3.3% | - | - |